Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-19-000476

Chief Executive Officer sold 703 shares at $222.01 ($156,073)

  • Chief Executive Officer acquired 703 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kummeth Charles R. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-10 Exercise or conversion : show line 1 in the form +703 $67.46 $47,424 136,459 D
2019-12-10 Sale : show line 2 in the form −703 $222.01 $156,073 135,756 D
Open-market sales · 703 sh · avg $222.01 · $156,073

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-10 Exercise or conversion : show line 3 in the form Stock Options (Right to Buy) −703 45,115 D
Loading xslF345X03/edgar.xml…